A Biomarker Study of ATH434 in Participants With MSA

Clinical trial NCT05864365 · COMPLETED

Trial details

NCT number: NCT05864365
Sponsor: Alterity Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple System Atrophy

Start date: 2023-05-23
Primary completion: 2025-02-26
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.